DLX-159
DLX-159 is a putatively non-hallucinogenic psychoplastogen of the tryptamine family which is under development for the treatment of major depressive disorder and other psychiatric disorders. It is taken orally.
DLX-159 is a putatively non-hallucinogenic psychoplastogen of the tryptamine family which is under development for the treatment of major depressive disorder and other psychiatric disorders. It is taken orally.
DLX-159 is a putatively non-hallucinogenic psychoplastogen of the tryptamine family which is under development for the treatment of major depressive disorder and other psychiatric disorders. It is taken orally.
Source: Wikipedia "DLX-159" · CC BY-SA 4.0
Share this article: X · Bluesky